<DOC>
	<DOCNO>NCT00629148</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy tolerability sequential use vinorelbine capecitabine first line therapy patient MBC .</brief_summary>
	<brief_title>Sequential Versus Simultaneous Use Vinorelbine Capecitabine Patients With Metastatic Breast Cancer ( MBC )</brief_title>
	<detailed_description>The administration vinorelbine capecitabine imply quite useful metastatic breast cancer . This study design explore whether sequential simultaneous use vinorelbine capecitabine similar efficacy whether sequential way well tolerability .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Signed informed consent . Female , ≥ 18 ≤ 70 year . Histologically confirm invasive breast cancer . Metastatic breast cancer . ECOG Performance Status 0 2 . Life expectancy 3 month . Subject must adequate organ function . Normal laboratory value : hemoglobin &gt; 90g/dl , neutrophil &gt; 1.5×10^9/L , platelet &gt; 80×10^9/L , serum creatinine &lt; 1.5×upper limit normal ( ULN ) , serum bilirubin &lt; 1.5×ULN , ALT AST &lt; 2.5×ULN . Negative serum pregnancy test woman childbearing potential . Good condition infusion willing phlebotomy throughout whole study . Have cease antitumor treatment include endocrinotherapy biotargeted therapy 28 day . Have least one target lesion accord Response Evaluation Criteria Solid Tumors ( RECIST ) criterion . Pregnant lactating female History malignancy . However , subject diseasefree 5 year , subject history completely resect nonmelanoma skin cancer successfully treat situ carcinoma eligible Concurrent disease condition would make subject inappropriate study participation , serious medical disorder would interfere subject 's safety Active uncontrolled infection Known history uncontrolled symptomatic angina , arrhythmia , congestive heart failure Concomitant brain metastasis Have receive chemotherapy metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>metastasis</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>Vinorelbine</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>sequential chemotherapy</keyword>
	<keyword>TTF</keyword>
</DOC>